Scarica l'app Stockscreener
5.295
3.22%
0.175
Precedente Chiudi:
$5.12
Aprire:
$5.16
Volume 24 ore:
359.33K
Relative Volume:
0.60
Capitalizzazione di mercato:
$266.71M
Reddito:
$230.47M
Utile/perdita netta:
$30.28M
Rapporto P/E:
8.6803
EPS:
0.61
Flusso di cassa netto:
$38.86M
1 W Prestazione:
+5.07%
1M Prestazione:
+18.23%
6M Prestazione:
+87.41%
1 anno Prestazione:
+85.44%
Intervallo 1D:
$5.13
$5.34
Intervallo di 1 settimana:
$5.01
$5.415
Portata 52W:
$2.32
$6.07
Puma Biotechnology Inc Stock (PBYI) Company Profile
Nome
Puma Biotechnology Inc
Settore
Industria
Telefono
(424) 248-6500
Indirizzo
10880 WILSHIRE BLVD., LOS ANGELES, CA
Confronta PBYI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
5.295 | 257.90M | 230.47M | 30.28M | 38.86M | 0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.08 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.75 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
804.49 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
328.98 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-09-28 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-06-25 | Ripresa | BofA/Merrill | Underperform |
| 2019-10-08 | Downgrade | Goldman | Neutral → Sell |
| 2019-05-10 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | Downgrade | Citigroup | Buy → Neutral |
| 2019-01-17 | Iniziato | Leerink Partners | Mkt Perform |
| 2019-01-03 | Downgrade | Guggenheim | Buy → Neutral |
| 2018-11-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-11-02 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-10-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-09-17 | Iniziato | Goldman | Sell |
| 2018-05-11 | Reiterato | Stifel | Buy |
| 2017-11-10 | Reiterato | Citigroup | Buy |
| 2017-11-10 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | Reiterato | Stifel | Buy |
| 2017-09-11 | Reiterato | Credit Suisse | Outperform |
| 2017-07-10 | Ripresa | Leerink Partners | Outperform |
| 2017-06-06 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | Reiterato | RBC Capital Mkts | Sector Perform |
Mostra tutto
Puma Biotechnology Inc Borsa (PBYI) Ultime notizie
Multi asset correlation models including Puma Biotechnology Inc.Market Activity Report & Entry Point Confirmation Signals - newser.com
Real time social sentiment graph for Puma Biotechnology Inc.July 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
Is now a turning point for Puma Biotechnology Inc.2025 Key Lessons & Real-Time Buy Zone Alerts - newser.com
Why Puma Biotechnology Inc. is moving todayExit Point & Low Drawdown Trading Strategies - newser.com
Exit strategy if you’re trapped in Puma Biotechnology Inc.2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Puma Biotechnology (NASDAQ:PBYI) Raised to Buy (B-) at Weiss Ratings - MarketBeat
What’s next for Puma Biotechnology Inc. stock price2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com
Leading vs lagging indicators on Puma Biotechnology Inc. performanceLong Setup & Accurate Technical Buy Alerts - newser.com
Published on: 2025-10-10 03:15:11 - newser.com
Analyzing drawdowns of Puma Biotechnology Inc. with statistical toolsJuly 2025 Weekly Recap & Fast Momentum Entry Tips - newser.com
Will Puma Biotechnology Inc. stock benefit from sector rotationMarket Trend Review & Free Reliable Trade Execution Plans - newser.com
Puma Biotechnology (NASDAQ:PBYI) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Momentum divergence signals in Puma Biotechnology Inc. chartJuly 2025 Market Mood & Safe Entry Momentum Tips - newser.com
Is Puma Biotechnology Inc. stock a safe investment in uncertain marketsSwing Trade & Daily Stock Momentum Reports - newser.com
Will Puma Biotechnology Inc. stock go up soonM&A Rumor & Safe Entry Point Identification - newser.com
Pattern recognition hints at Puma Biotechnology Inc. upsideCEO Change & Fast Momentum Entry Tips - newser.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635c4 - MarketScreener
Comparing Puma Biotechnology Inc. in custom built stock radarsJuly 2025 Retail & Daily Stock Trend Reports - newser.com
Live market analysis of Puma Biotechnology Inc.Trade Entry Summary & Fast Gain Stock Trading Tips - newser.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)October 2, 2025 - BioSpace
Puma Biotechnology reports inducement awards under Nasdaq listing rule - MarketScreener
Barclays Maintains a Sell Rating on Puma Biotechnology (PBYI) With a $2 PT - MSN
What Do Analysts Think About Puma Biotechnology (PBYI)? - MSN
What analysts say about Puma Biotechnology Inc stockEarnings Per Share Trends & Low Entry Investment Ideas - earlytimes.in
Using data tools to time your Puma Biotechnology Inc. exitEarnings Overview Summary & Accurate Intraday Trading Signals - newser.com
September 2025's Promising Penny Stocks Revealed - simplywall.st
Puma Biotechnology Inc Stock Analysis and ForecastLow Risk Investment Ideas & Free Stay Informed With Forecasts - earlytimes.in
Tools to monitor Puma Biotechnology Inc. recovery probabilityJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
Puma Biotechnology Inc Azioni (PBYI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):